Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine e...

Full description

Bibliographic Details
Main Authors:	Gilbert, S, Collins, K, Snaith, R, Cottingham, M, Hill, A
Format:	Journal article
Published:	Nature Publishing Group 2017

Similar Items

Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity
by: Chauveau, L, et al.
Published: (2021)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
by: Jerri C. Caldeira, et al.
Published: (2020-04-01)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
by: Schneider, J, et al.
Published: (1998)

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice
by: Katharine A. Collins, et al.
Published: (2021-05-01)

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
by: Dégano, P, et al.
Published: (1999)

Protein particle vaccines against malaria.
by: Gilbert, S, et al.
Published: (1997)

Virus-like particles as vaccine adjuvants.
by: Gilbert, S
Published: (2001)

Virus-like particle vaccines
by: Mukhopadhyay, E, et al.
Published: (2022)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
by: Moorthy, V, et al.
Published: (2003)

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease
by: Bennett J. Davenport, et al.
Published: (2022-05-01)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
by: Hyeon-Jeong Go, et al.
Published: (2021-11-01)

Virus-like Particle Vaccines of Infectious Bursal Disease Virus Expressed in <i>Escherichia coli</i> Are Highly Immunogenic and Protect against Virulent Strain
by: Pengchao Ji, et al.
Published: (2023-10-01)

Immunization with Virus-Like Particle Vaccine Protects Rabbits against Hepatitis E-3 Virus Infection
by: Hyeon-Jeong Go, et al.
Published: (2022-06-01)

Immunogenicity and protective efficacy of a novel bacterium-like particle-based vaccine displaying canine distemper virus antigens in mice and dogs
by: Jianzhong Wang, et al.
Published: (2024-04-01)

Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine.
by: Erin M Jackson, et al.
Published: (2012-01-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
by: Dicks, M, et al.
Published: (2011)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
by: Draper, S, et al.
Published: (2005)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
by: Mcshane, H, et al.
Published: (2001)

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
by: Draper, S, et al.
Published: (2010)

Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium berghei/vivax
by: Cabral-Miranda, G, et al.
Published: (2017)

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
by: Gustavo Cabral-Miranda, et al.
Published: (2017-05-01)

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.
by: de Cassan, S, et al.
Published: (2011)

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
by: Ambühl, P, et al.
Published: (2007)

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
by: Dan Xu, et al.
Published: (2024-11-01)

Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens
by: Celia Abolnik, et al.
Published: (2022-06-01)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
by: Gilbert, S, et al.
Published: (2002)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
by: Gilbert, S, et al.
Published: (1999)

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
by: Fenlian Ma, et al.
Published: (2023-10-01)

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.
by: Irina Margine, et al.
Published: (2012-01-01)

Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles
by: Lin-Feng Cheng, et al.
Published: (2016-12-01)

Potent Protective Immune Responses to <i>Senecavirus</i> Induced by Virus-Like Particle Vaccine in Pigs
by: Suyu Mu, et al.
Published: (2020-09-01)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.
by: Moore, A, et al.
Published: (2005)

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
by: Saghi Nooraei, et al.
Published: (2021-02-01)

Immunogenicity of vaccines for malaria-exposed populations
by: Bowyer, GSA
Published: (2018)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
by: Katrin Kramer, et al.
Published: (2019-01-01)

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
by: Spencer, A, et al.
Published: (2014)

Uncovering the mechanisms of adenovirus vector immunogenicity
by: Dicks, M, et al.
Published: (2013)

Heterologous vaccine immunogenicity, efficacy, and immune correlates of protection of a modified-live virus porcine reproductive and respiratory syndrome virus vaccine
by: Jessica Proctor, et al.
Published: (2022-09-01)

Effects of the Japanese Encephalitis Virus Genotype V-Derived Sub-Viral Particles on the Immunogenicity of the Vaccine Characterized by a Novel Virus-Like Particle-Based Assay
by: Sarah Honjo, et al.
Published: (2019-08-01)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
by: Goepfert P, et al.
Published: (2012-09-01)